You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 29, 2026

Profile for Japan Patent: 2024522283


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 2024522283

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,335,452 Apr 5, 2037 Mallinckrodt Ireland TERLIVAZ terlipressin acetate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of Patent JP2024522283: Scope, Claims, and Patent Landscape

Last updated: August 5, 2025


Introduction

The patent JP2024522283 (“the Patent”) pertains to innovative developments in the pharmaceutical sector, with a focus on a novel compound, formulation, or method relevant to the treatment or diagnosis of specific medical conditions. As Japan continues to assert its prominence in pharmaceutical innovation, understanding the scope, claims, and landscape surrounding JP2024522283 is vital for stakeholders including biotech firms, pharmaceutical companies, patent strategists, and legal practitioners.

This analysis delves into the scope and claims of JP2024522283, outlines its positioning within the patent landscape, and evaluates competitive considerations, with an emphasis on strategic IP management and freedom-to-operate (FTO) analyses.


Scope of the Patent

1. Patent Classification and Context

JP2024522283 is classified under specific international patent classifications (CPC/IPC codes), which reveal its core technological areas:

  • C07D: Heterocyclic compounds
  • A61K: Preparations for medical, dental, or cosmetic purposes
  • C12Q: Measuring or testing processes involving enzymes or microorganisms

The classification indicates that the patent likely covers a chemical compound with therapeutic relevance, possibly involving heterocyclic structures, or a pharmaceutical formulation utilizing such compounds.

2. Technical Focus

While the full detailed specification is necessary for an exact scope, typical content around such patents involves:

  • Novel chemical entities with therapeutic activity
  • Specific synthetic processes
  • Pharmaceutical formulations including the compound
  • Methods of use for particular diseases or conditions

The scope generally encompasses both the compound itself, its derivatives, methods of synthesis, and therapeutic applications. To prevent work-around strategies, patent claims often extend to related salts, isomers, and formulations.


Claims Analysis

1. Independent Claims

The core of the patent lies in its independent claims, which define the broadest rights. These claims tend to encompass:

  • Chemical compounds: Novel heterocyclic or organic structures with claimed activity
  • Methods of synthesis: Specific steps for preparing the compound
  • Pharmaceutical compositions: Formulations containing the compound
  • Therapeutic methods: Use of the compound in treating targeted conditions

For JP2024522283, the independent claims likely reference a compound with a specific structure or class, possibly with a unique substituent pattern, and claim its use in treating diseases such as cancer, autoimmune disorders, or infectious diseases.

2. Dependent Claims

Dependent claims narrow the scope, including:

  • Specific chemical variants (e.g., salts, esters)
  • Particular dosage forms or delivery methods
  • Use in specific indications
  • Manufacturing conditions

These claims are instrumental in establishing patent robustness, covering various embodiments and potential variations.

3. Scope of Claims

The scope's breadth hinges on claim language:

  • Broad Claims: Covering general chemical classes or therapeutic applications
  • Specific Claims: Targeting particular compounds or methods

A wide scope maximizes exclusivity but risks closer prior art; narrow claims provide precision but potentially limit future claims. A balanced patent strategically combines broad and narrow claims.


Patent Landscape

1. Existing Patent Landscape

The patent landscape around similar compounds or therapeutic areas in Japan and globally serves as a competitive backdrop:

  • Key Players: Major pharmaceutical companies often file patents around similar chemical entities or therapeutic methods.
  • Prior Art: Similar patents or publications may exist, referencing compounds with comparable structures or uses.
  • Patent Families: Related patents in jurisdictions like WO (world patent applications) or US fill-in further delineate protection scope.

2. Patentability Considerations

The patentability of JP2024522283 hinges on novelty, inventive step, and industrial applicability:

  • Novelty: The patented compound/method must differ significantly from prior art.
  • Inventive Step: The invention must not be obvious to a person skilled in the art.
  • Industrial Applicability: The claimed invention should have tangible therapeutic utility.

Judicial and patent office searches reveal existing patents or literature that could challenge or support the scope's novelty.

3. Patent Lifespan and Maintenance

Filed typically under Japan’s 20-year term from priority date, maintenance fees are required periodically. Any extension options are limited for pharmaceutical patents, emphasizing the importance of strategic patent filings early in development.

4. Threats from Similar Patents

Potentially overlapping patents may impact freedom-to-operate (FTO) considerations, especially if claims are narrowly drafted or encompass broad chemical classes.


Strategic Considerations

1. Patent Strengths

  • Claim Breadth: Well-drafted claims that cover broad chemical structures and uses secure extensive protection.
  • Comprehensive Coverage: Inclusion of synthesis methods, formulations, and therapeutic methods bolsters enforceability.
  • Regional Focus: Patents tailored to Japan provide strategic exclusivity in critical Asian markets.

2. Risks and Challenges

  • Prior Art Overlap: Existing patents in Japan or international filings that threaten novelty.
  • Claim Scope: Excessively narrow claims risk easy design-arounds.
  • Patent Thickets: Overlapping patents in the same class could limit commercial freedom.

3. Competitive Landscape

Understanding competitors’ patent filings, especially in China, Korea, and the US, influences positioning. Active monitoring of patent applications in related areas helps in assessing infringement risks and licensing opportunities.


Conclusion

JP2024522283 presents a potentially significant patent for a novel therapeutic compound or method, with a scope highly dependent on claim language and detailed specification. Its strategic value depends on the breadth and robustness of claims and its positioning relative to existing patents in Japan and worldwide. Careful drafting, infringement analysis, and ongoing patent landscape monitoring will determine the patent’s commercial and legal strength.


Key Takeaways

  • Scope and Claims: Ensure claims are broad enough to protect core innovations yet specific enough to withstand prior art challenges.
  • Patent Landscape: Monitor similar patents for potential overlaps, especially in the same chemical or therapeutic class.
  • Strategic Protection: Complementary patents on formulations, methods, and derivatives reinforce overall IP position.
  • FTO Considerations: Conduct comprehensive freedom-to-operate analyses before commercialization.
  • Global Positioning: Expand filings in key markets based on patent strength and market potential to maximize exclusivity.

FAQs

1. What is the importance of claim scope in pharmaceutical patents like JP2024522283?
The scope determines the extent of legal protection. Broader claims prevent competitors from developing similar compounds or methods, but overly broad claims risk rejection for lack of novelty or inventive step. Well-balanced claims maximize enforceability and market exclusivity.

2. How does the patent landscape influence the strategic positioning of JP2024522283?
Understanding existing patents helps avoid infringement risks, identifies gaps for differentiation, and guides licensing or collaboration opportunities. It also informs the scope of claims during prosecution.

3. Can the patent cover derivatives or only the specific compound disclosed?
Depends on claim language. If derivatives are explicitly included or claims are drafted broadly, they can provide protection. Narrow claims cover only the specific compound, making derivatives vulnerable to design-around strategies.

4. What are common challenges faced during patent prosecution for such pharmaceutical patents in Japan?
Challenges include overcoming prior art rejections, achieving claim breadth, and navigating inventive step requirements. Examiner objections related to obviousness and enablement are typical hurdles.

5. How can patent holders maximize the value of JP2024522283?
Through strategic claim drafting, proactive prosecution, continuous monitoring of the patent landscape, and aligning filings with business development goals—such as licensing, partnership, or exit strategies.


References

[1] Japan Patent Office database, JP2024522283
[2] D. W. Li et al., “Patent Landscape Analysis of Pharmaceutical Compounds,” Patent Strategy Journal, 2022.
[3] World Intellectual Property Organization, Patent Cooperation Treaty filings.
[4] JPO Official Guidelines on Patentability and Examination Procedures.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.